Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy for Vulvar Cancer
NCT05916690Recruiting
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Mar 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bleomycin and cisplatin in vulvar cancer, sponsored by Institute of Oncology Ljubljana. Primary endpoints: Number of adverse events at 12 months and Response of the tumor to electrochemotherapy according to RECIST criteria at 12 months. Started Mar 2021; status: recruiting.
02
Drugs
bleomycincisplatin
03
Conditions
vulvar cancer
Beyond the preview
Go deeper on NCT05916690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05916690.